Dutrebis
Active substance: lamivudine, raltegravir potassium
lamivudine, raltegravir potassium
Centralised EU authorisationWithdrawn
Marketing holder: Merck Sharp Dohme Limited
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| RU 113 |
|
| US 53 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-397d-767a-b896-70baaf32d509,01a120c3-3eb2-720d-96d0-26034ced2ff5,01a120c3-4146-7719-8056-f4be8450b4bc,01a120c3-4416-740a-95b6-c025ec9581cf,01a120c3-4a43-779b-b1cb-af99d70a953b;count=47 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-8481-7076-abd3-8bb5dd6a49d8,01a1208d-7a49-730c-a993-8750076b7fe3,01a1208d-8cfa-7da0-b9b2-9539a181c6cf,01a1208d-94f5-7cf5-9063-d62c05ce0f4e,01a1208e-16f1-75e3-8269-bd03dd3cafc2;count=29 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- EMEA/H/C/003823
- Registration status
- Withdrawn
- ATC code
- J05AR16
- product · EMA · EMEA/H/C/003823 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/003823 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/003823 · Verified 2026-10-09
- ingredients.1 · EMA · EMEA/H/C/003823 · Verified 2026-10-09